Category

News
Iowa Medicaid no longer requires severe liver damage for patients to access hepatitis C treatment, but strict sobriety and prescriber requirements continue to limit treatment availability. July 1, 2020 – The National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today applauded Iowa for removing...
Read More
Increasing access to treatment will help Ohio increase hepatitis C treatment rates for more than 2.6 million Ohioans enrolled in Medicaid. May 21, 2020 – The National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today applauded Ohio removing discriminatory sobriety restrictions on access to...
Read More
Increasing access to treatment will help Puerto Rico eliminate hepatitis C and improve treatment options for more than one million Puerto Ricans. April 27, 2020 – The National Viral Hepatitis Roundtable (NVHR), a national coalition working to eliminate viral hepatitis, and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) today applauded...
Read More
New article by Ed Silverman for Managed Care Magazine details that some states still limit hepatitis C treatment for Medicaid patients. “Restrictions blunted the effect of Sovaldi and other antivirals on Medicaid budgets. The gradual removal of these barriers is going too slowly, say advocates.” Click here to read the full article.
Read More
The Bozeman Daily Chronicle reports on the improvements made by the state’s Medicaid program to expand access to hepatitis C treatment for Medicaid patients. Click here to read the full article.
Read More
New article from Michael Ollove at Stateline documents how more state Medicaid programs are being required to expand access to treatment for patients and make direct-acting antivirals more broadly available. Click here to read the full article.  
Read More
Beckers ASC Review outlines six findings from Hepatitis C: State of Medicaid Access on hepatitis C treatment restrictions. Click here to read the full article.
Read More
Medpage Today reports that many Medicaid programs still impose hepatitis C treatment restrictions not supported by medical evidence, referencing findings from Hepatitis C: State of Medicaid Access. Click here to read full article.
Read More
The Bozeman Daily Chronicle editorializes in favor of changing Montana’s Medicaid access policy for hepatitis C treatments, citing the state’s ‘F’ grade in Hepatitis C: State of Medicaid Access. Click here to read full article.
Read More
The Bozeman Daily Chronicle reports on Montana’s ‘F’ grade in Hepatitis C: State of Medicaid Access. Click here to read full article.
Read More
1 2